IL4 and Alzheimer disease: In addition, ROS promote Th2-skewed immune responses and impair Treg function (Nakajima et al., 2021), resulting in the upregulation of type 2 cytokines such as IL-4 and IL-13 (Fu Z. et al., 2024), which further exacerbate chronic allergic inflammation in AD.